Full Press Release Details
("Midatech", "Company"
Completion of Midatech Pharma US Sale
Midatech Pharma (AIM: MTPH, Nasdaq: MTP),
the R&D company focused on delivering innovative oncology and rare disease products to patients, is pleased to announce that,
further to recent Company updates, the proposed sale of Midatech Pharma US Inc. ("MTP US") to Kanwa Holdings, LP has
Kanwa Holdings, LP is a limited partnership
established for the purposes of acquiring MTP US. It is owned by Funds managed by or through Barings LLC.
For more information, please contact:
Panmure Gordon (UK) Limited (Nominated Adviser and Broker)
Corporate finance: Freddy Crossley / Emma Earl
Corporate broking: James Stearns
Consilium Strategic Communications (Financial PR)
Mary Jane Elliott / Nicholas Brown / Angela Gray
Westwicke Partners (US Investor Relations)
Kelly Smith - Global Head of Media
Midatech Pharma (LSE AIM: MTPH; NASDAQ:
MTP) is an R&D company focused on delivering innovative oncology and rare disease products to patients. The Company is developing
a range of improved chemotherapeutics or new immunotherapeutics, using its three proprietary platform drug delivery technologies,
all of which are in the clinic, specifically:
Each of our three technologies are thus
focussed on improved bio-delivery and bio-distribution of medicines or agents to areas of the body where they are needed and can
exert their actions in an effective, safe and precise manner.
Midatech is headquartered in Oxfordshire,
with an R&D facility in Cardiff and a manufacturing operation in Bilbao, Spain. For more information please visit www.midatechpharma.com.
Barings is a $310+ billion* global financial services firm dedicated
to meeting the evolving investment and capital needs of its clients. Barings builds lasting partnerships that leverage its distinctive
expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. Part of MassMutual,
Barings maintains a strong global presence with over 1,900 professionals and offices in 16 countries. Learn more, at www.barings.com.
* As of September 30, 2018.
Forward Looking Statements
Certain statements in this press release may constitute "forward-looking
statements" within the meaning of legislation in the United Kingdom and/or United States. These statements typically contain
words such as "intends", "expects", "anticipates", "estimates" and words of similar import.
Any forward-looking statements are based on currently available competitive, financial and economic data together with management's
views and assumptions regarding future events and business performance as of the time the statements are made and are subject to
risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. There are a number
of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking
statements. These factors include, but are not limited to, the following possibilities: operational challenges in achieving strategic
objectives and executing plans; future revenues are lower than expected; costs or difficulties relating to the sale of MTP US and
the continuation of the Group's business following the sale, are greater than expected; competitive pressures in the industry increase;
general economic conditions or conditions affecting the Group's business following the sale of MTP US, whether internationally
or in the places where the Group does business, are less favourable than expected; and/or conditions in the securities market are
less favourable than expected.
Statements are only made as at the date of this document. The
Company expressly disclaims any obligation to disseminate any update or revision to any forward looking statement in this document
to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such
statement is based, unless required to do so by applicable law, the AIM Rules or the rules and regulations of the U.S. Securities
and Exchange Commission.